UI Health Hospital

Chicago, Illinois 60612

2 studies enrolling now · 3 studies all time

What they study most

Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Pulmonary Arterial Hypertension

Studies at this site

• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed